TriLink BioTechnologies Extends EyeGene Partnership for COVID-19 Vaccine Development in South Korea.
TriLink BioTechnologies, a Maravai LifeSciences for research, diagnostics and therapeutics applications, announced that it expects to supply its proprietary...
|